SHPMF (Shanghai Pharmaceuticals Holding Co) Interest Expense: $-225 Mil (TTM As of Mar. 2026)


SHPMF Shanghai Pharmaceuticals Holding Co Ltd SHPMF
77 GF Score
Price $1.46
GF Value $1.86
! 4 Warning Signs
View Full Analysis

What is Shanghai Pharmaceuticals Holding Co Interest Expense?

Shanghai Pharmaceuticals Holding Co SHPMF -4.58% 77 Interest Expense is $-225 Mil as of Mar. 2026. GuruFocus rates SHPMF with a GF Score™ of 77/100 and a GF Value™ of $1.86. The stock has 4 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Shanghai Pharmaceuticals Holding Co's interest expense for the three months ended in Mar. 2026 was $ -50 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was $-225 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Shanghai Pharmaceuticals Holding Co's Operating Income for the three months ended in Mar. 2026 was $ 421 Mil. Shanghai Pharmaceuticals Holding Co's Interest Expense for the three months ended in Mar. 2026 was $ -50 Mil. Shanghai Pharmaceuticals Holding Co's Interest Coverage for the quarter that ended in Mar. 2026 was 8.35. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Shanghai Pharmaceuticals Holding Co  (OTCPK:SHPMF) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Shanghai Pharmaceuticals Holding Co's Interest Expense for the three months ended in Mar. 2026 was $-50 Mil. Its Operating Income for the three months ended in Mar. 2026 was $421 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was $685 Mil.

Shanghai Pharmaceuticals Holding Co's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Interest Coverage=-1* Operating Income (Q: Mar. 2026 )/Interest Expense (Q: Mar. 2026 )
=-1*421.013/-50.441
=8.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Shanghai Pharmaceuticals Holding Co Interest Expense Historical Data

* Premium members only.

The historical data trend for Shanghai Pharmaceuticals Holding Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Pharmaceuticals Holding Co Interest Expense Chart

Shanghai Pharmaceuticals Holding Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -238.37 -242.31 -264.00 -255.02 -239.36

Shanghai Pharmaceuticals Holding Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -61.26 -61.78 -55.17 -57.53 -50.44
SHPMF
77GF Score
Shanghai Pharmaceuticals Holding Co Ltd SHPMF
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Pharmaceuticals Holding Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-225 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of $-225 Mil mean?
Shanghai Pharmaceuticals Holding Co (SHPMF) has a Interest Expense of $-225 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Shanghai Pharmaceuticals Holding Co and its competitors.
Is Shanghai Pharmaceuticals Holding Co's Interest Expense too high?
Shanghai Pharmaceuticals Holding Co's current Interest Expense is $-225 Mil. Overall, Shanghai Pharmaceuticals Holding Co has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Shanghai Pharmaceuticals Holding Co's Interest Expense compare to MCK and CAH?
Shanghai Pharmaceuticals Holding Co's Interest Expense of $-225 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Medical Distribution company?
A good Interest Expense depends on the Medical Distribution industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Shanghai Pharmaceuticals Holding Co and its competitors. Shanghai Pharmaceuticals Holding Co's current Interest Expense is $-225 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Pharmaceuticals Holding Co stock overvalued right now?
Shanghai Pharmaceuticals Holding Co (SHPMF) has a current Interest Expense of $-225 Mil. The stock's GF Value™ is $1.86, compared to a current price of $1.46 — trading 21.5% below its estimated fair value. The current Interest Expense is $-225 Mil. Shanghai Pharmaceuticals Holding Co's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Shanghai Pharmaceuticals Holding Co (SHPMF), the current Interest Expense is $-225 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Pharmaceuticals Holding Co (SHPMF) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Pharmaceuticals Holding Co stock appears to be undervalued. The current stock price of $1.46 is trading 21.5% below its estimated GF Value™ of $1.86.

Key valuation signals for SHPMF:

  • Interest Expense: $-225 Mil
  • GF Value™: $1.86 vs. price of $1.46 (21.5% below fair value)
  • GF Score™: 77/100 with 4 warning signs

No single metric tells the full story. See the SHPMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai Pharmaceuticals Holding Co Business Description

Address No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020
Shanghai Pharmaceuticals Holding Co Ltd is engaged in the pharmaceutical drug development and distribution business. The Group's reportable segments are: Production, Distribution, Retail, and Other. The majority of its revenue comes from the Distribution segment, which is mainly engaged in distribution, warehousing, and other value-added pharmaceutical supply chain solutions and related services for pharmaceutical manufacturers and dispensers. The Retail segment operates a network of retail pharmacy stores, and the Production segment is mainly engaged in research and development, production, and sales of a broad range of pharmaceutical and healthcare products. Geographically, the Group mainly operates in the People's Republic of China (PRC).
77GF Score

Get the complete analysis for SHPMF

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.46
Price
$1.86
GF Value